James B Chung Selected Research

AMG 557

1/2018

Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James B Chung Research Topics

Disease

4	Psoriatic Arthritis 01/2021 - 01/2018
3	Rheumatoid Arthritis 01/2021 - 10/2013
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 10/2015
1	Pain (Aches) 06/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018
1	Arthritis (Polyarthritis) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Discoid Lupus Erythematosus 01/2017
1	Lupus Nephritis 01/2017
1	Proteinuria 01/2017
1	Lyme Disease (Disease, Lyme) 06/2002

Drug/Important Bio-Agent (IBA)

6	Etanercept (Enbrel)FDA Link 01/2021 - 01/2018
5	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 10/2013
3	Monoclonal AntibodiesIBA 01/2017 - 10/2013
3	InterferonsIBA 01/2017 - 10/2015
3	AMG 811IBA 01/2017 - 10/2015
2	Tumor Necrosis Factor InhibitorsIBA 06/2019 - 01/2017
1	Phosphates (Orthophosphate)IBA 06/2019
1	apremilastIBA 10/2018
1	LigandsIBA 01/2018
1	AMG 557IBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	anti-dsDNA autoantibodyIBA 01/2017
1	Antirheumatic Agents (DMARD)IBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	Interleukin-18 (Interleukin 18)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Complement C4 (Complement Component 4)IBA 01/2017
1	Complement C3 (C3 Complement)IBA 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 10/2015
1	brodalumabIBA 10/2013
1	Lyme Disease VaccinesIBA 06/2002
1	VaccinesIBA 06/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2018
1	Subcutaneous Injections 06/2019